Current status and prospect of treatments for recurrent hepatocellular carcinoma

doi:10.4254/wjh.v15.i2.129

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4065)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

184

WORD

HTML

2709

Figures (1-1)

200

Tables (1-3)

291

Sum=3430

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

228

Download

407

Sum=635

Feb 27, 2023 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Feb 27, 2023; 15(2): 129-150
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.129

Full Size Figure Download Figure

Figure 1 Suggested flowchart of recurrent hepatocellular carcinoma management. SBRT: Stereotactic body radiotherapy; TACE: Transcatheter arterial chemoembolization.

Citation: Yang YQ, Wen ZY, Liu XY, Ma ZH, Liu YE, Cao XY, Hou L, Xie H. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(2): 129-150
URL: https://www.wjgnet.com/1948-5182/full/v15/i2/129.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i2.129